Ivan Hyep - 02 Feb 2026 Form 4 Insider Report for Bicara Therapeutics Inc. (BCAX)

Role: Chief Financial Officer
Signature: /s/ Lara Meisner, Attorney-in-Fact
Issuer symbol: BCAX
Transactions as of: 02 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 04 Feb 2026, 16:35:08 UTC
Previous filing: 26 Jan 2026
Next filing: 05 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hyep Ivan	Chief Financial Officer	BICARA THERAPEUTICS INC., 116 HUNTINGTON AVENUE, SUITE 703, BOSTON	/s/ Lara Meisner, Attorney-in-Fact	04 Feb 2026	0002034668

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BCAX	Stock Option (Right to Buy)	Award	$0	+125,000		$0.000000	125,000	02 Feb 2026	Common Stock	125,000	$16.76	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying this option vest in sixteen equal quarterly installments following February 2, 2026, subject to the Reporting Person's continued service on each such vesting date.